Celgene Corporation to Acquire Juno Therapeutics, Inc., Advancing Global Leadership in Cellular Immunotherapy
Go back to Celgene Corporation to Acquire Juno Therapeutics, Inc., Advancing Global Leadership in Cellular Immunotherapy| Celgene Corp. (NASDAQ: CELG) | Delayed: 108.24 --0 (-0%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $108.24 | 52 Week High | $127.00 | |||
| Open | $7.85 | 52 Week Low | $93.05 | |||
| Day High | $108.24 | P/E | 32.12 | |||
| Day Low | $108.24 | EPS | $3.37 | |||
| Volume | 0 | |||||
| (NASDAQ: JUNO) | Delayed: 86.96 --0 (-0%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $86.96 | 52 Week High | $57.82 | |||
| Open | $10.20 | 52 Week Low | $22.37 | |||
| Day High | $86.96 | P/E | N/A | |||
| Day Low | $86.96 | EPS | $0.00 | |||
| Volume | 1 | |||||
